Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Screening And Future Enhanced MRI

Project description

Green imaging: sustainable solutions for breast cancer screening

Many women aged 45 to 50 are currently excluded from routine breast cancer screening, leading to preventable deaths. Additionally, traditional MRI scans require contrast dyes that pose health risks and pollute the environment. The ERC-funded SAFE-MRI project aims to revolutionise screening by introducing a one-time, abbreviated MRI for this younger age group to detect cancer early. To improve safety, the project will use deep learning and advanced imaging to reduce or eliminate the need for these contrast agents. By validating faster, unenhanced scans, SAFE-MRI seeks to create a more effective and eco-friendly screening model. Ultimately, this initiative will save lives and define the future of breast cancer prevention.

Objective

SAFE-MRI aims to prevent needless mortality from breast cancer by optimizing the use and performance of dedicated breast MRI.
First SAFE-MRI aims at detecting breast cancer early in women that are currently deemed too young for population screening (age 45-50). Early diagnosis of breast cancer in these women will lead to a large gain in DALYs averted. I will initiate a prospective screening study inviting women to a one-time only abbreviated breast MRI at the age of 45. The primary outcome will be the cancer detection rate per 1000 women actually screened. This will validate abbreviated breast MRI as standalone screening technique. Psycho-social and risk information will be collected from all participants. Cost-effectiveness modelling will be included. 5-year follow-up will be performed in all women up to, and including, the first screening round at the age of 50.
Second SAFE-MRI aims at improving breast MRI by reducing the need for contrast administration. This is a major downside of breast MRI - for women (iv-canulation and a small risk of allergic reactions) and the environment (pollution of surface water). First, I aim to enhance signal changes using a strongly reduced dose of contrast with advanced deep learning (DL). Further studies are tailored at assessment of unenhanced MRI. Particularly, I will validate novel diffusion weighted imaging (DWI) sequences capable of generating high resolution diagnostic images within short scan times using DL-based reconstruction. Furthermore, I will investigate arterial spin labelling (ASL) based breast imaging strategies that show perfusion without the need for contrast administration. Finally, we will combine unenhanced MRI techniques in a general adversarial network to construct synthetic breast MRI images. Repeated reader studies will be conducted to assess image quality and diagnostic value. SAFE-MRI will thus consolidate my leading role in breast imaging and enable me to design the breast screening of the future.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-ERC - HORIZON ERC Grants

See all projects funded under this funding scheme

Call for proposal

(opens in new window) ERC-2022-COG

See all projects funded under this call

Host institution

STICHTING RADBOUD UNIVERSITAIR MEDISCH CENTRUM
Net EU contribution
€ 2 984 796,00
Address
GEERT GROOTEPLEIN 10 ZUID
6525 GA Nijmegen
Netherlands
Region
Oost-Nederland Gelderland Arnhem/Nijmegen
Activity type
Higher or Secondary Education Establishments
Links
Total cost
€ 2 984 796,00

Beneficiaries (1)